Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00576420 · ClinicalTrials.gov registry record · Phase 2
Fibrin Sealant Vascular Surgery Study
A Phase 2 study, sponsored by Baxter Healthcare Corporation.
- Completed
- Registry status
- Phase 2
- Development phase
- 101
- Enrollment target
NCT00576420 is a Phase 2 study that has completed, run by Baxter Healthcare Corporation. The registered enrollment target is 101 participants.
The verdict
NCT00576420, a Phase 2 study, has completed, sponsored by Baxter Healthcare Corporation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 101 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy and safety of Fibrin Sealant, Vapor Heated, Solvent/Detergent-treated with 500 IU/ml thrombin and synthetic aprotinin (FS VH S/D 500 s-apr) for hemostasis in participants receiving prosthetic expanded polytetrafluoroethylene (ePTFE) conduits as compared to a control group treated by manual compression with surgical gauze pads.
Interventions
- BIOLOGICAL FS VH S/D 500 s-apr, 60-seconds polymerization time
- BIOLOGICAL FS VH S/D 500 s-apr, 120-seconds polymerization time
- PROCEDURE Manual compression with surgical gauze pads
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2007-12 |
| Est. Completion | 2008-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00576420
The ClinicalTrials.gov registry entry for NCT00576420 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baxter Healthcare Corporation, which has 46 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which FS VH S/D 500 s-apr, 60-seconds polymerization time is the first listed.
NCT00576420 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00576420 about?
NCT00576420 is a clinical study titled "Fibrin Sealant Vascular Surgery Study". The purpose of this study is to evaluate the efficacy and safety of Fibrin Sealant, Vapor Heated, Solvent/Detergent-treated with 500 IU/ml thrombin and synthetic aprotinin (FS VH S/D 500 s-apr) for hemostasis in participants receiving prosthetic expanded polytetrafluoroethylene (ePTFE) conduits as c...
What is the current status of trial NCT00576420?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 101 participants. The study started on 2007-12. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00576420?
The interventions under investigation include: FS VH S/D 500 s-apr, 60-seconds polymerization time (BIOLOGICAL), FS VH S/D 500 s-apr, 120-seconds polymerization time (BIOLOGICAL), Manual compression with surgical gauze pads (PROCEDURE).
Who is sponsoring clinical trial NCT00576420?
This trial is sponsored by Baxter Healthcare Corporation, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.